Reji John is a Nephrology physician. OpenAlex indexes 7 publications with 742 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2965 Harrison St Ste 222
Beaumont, TX 777021100
Telephone
409-892-1003Provider last certified this registry record 22 Apr 2024.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Mallinckrodt Hospital Products Inc.Program year20252 payments
- AstraZeneca Pharmaceuticals LPProgram year20252 payments
- Calliditas Therapeutics US Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
41.3%Loop diuretic8.9%Furosemide87%Bumetanide13%Part D<11 patientsCalcium channel blocker6.3%Amlodipine Besylate65%Nifedipine Er35%Part D≥30 patients+ 12 more classes in this area
Metabolism & gastrointestinal
27%SGLT2 inhibitor12.9%Farxiga75%Jardiance20%Dapagliflozin5%Part D<11 patientsSerotonin-3 Receptor Antagonist2.7%Ondansetron Hcl66%Ondansetron Odt35%Part D<11 patients+ 8 more classes in this area
Other
13.4%Phosphate Binder7.2%Sevelamer Carbonate100%Part D≥61 patientsDrugs for treatment of hyperkalemia and hyperphosphatemia6.2%Velphoro56%Lokelma19%Auryxia15%Lanthanum Carbonate11%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury
Kidney International
2010 - IRF-1 Promotes Inflammation Early after Ischemic Acute Kidney Injury
Journal of the American Society of Nephrology
2009 - Maladaptive Role of IL-6 in Ischemic Acute Renal Failure
Journal of the American Society of Nephrology
2005 - Impact of bile duct ligation on portal venous infection with E. coli: Role of interleukin 10
Journal of Gastrointestinal Surgery
2005
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”